FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Colonic Neoplasms / drug therapy*
• Colonic Neoplasms / mortality
• Colonic Neoplasms / pathology*
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Drug Approval
• Female
• Fluorouracil / therapeutic use*
• Humans
• Leucovorin / therapeutic use*
• Male
• Maximum Tolerated Dose
• Neoplasm Invasiveness / pathology*
• Neoplasm Staging
• Organoplatinum Compounds / therapeutic use*
• Oxaliplatin
• Prognosis
• Randomized Controlled Trials as Topic
• Survival Analysis
• Treatment Outcome
• United States
• United States Food and Drug Administration